Tampa, FL– With the use of robotic-assisted minimally invasive surgical procedures, patients experience faster recovery, less pain and lower risk for complications. As the first Moffitt Cancer Center physician to perform these procedures, Dr. Julio Pow-Sang has been named Director of the Moffitt Robotics Program.
“I plan to continue creating the environment so our surgeons can take robotic surgery to the next level and Moffitt can become one of the premiere robotic surgery institutions in the country,” Dr. Pow-Sang said. “There are additional surgeries that few centers perform that we are now doing at Moffitt, which offers an opportunity for research in outcomes.”
Because a growing number of surgeons are gaining expertise in this approach and its expanding applications, a need for management of the program was essential to oversee development of new applications. Dr. Pow-Sang plans to develop educational programs to train the future generations of surgeons in robotic procedures.
Moffitt first initiated robotic procedures in June, shortly after acquiring its first da Vinci® robot. More than 280 da Vinci assisted minimally invasive surgical procedures have been performed for cancer diagnoses ranging from prostate cancer, to gynecologic and thoracic malignancies.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.